Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fortress Biotech (FBIO) EBT: 2009-2024

Historic EBT for Fortress Biotech (FBIO) over the last 16 years, with Dec 2024 value amounting to -$120.5 million.

  • Fortress Biotech's EBT rose 133.25% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$74.8 million, marking a year-over-year increase of 36.72%. This contributed to the annual value of -$120.5 million for FY2024, which is 21.54% up from last year.
  • According to the latest figures from FY2024, Fortress Biotech's EBT is -$120.5 million, which was up 21.54% from -$153.6 million recorded in FY2023.
  • In the past 5 years, Fortress Biotech's EBT registered a high of -$102.8 million during FY2020, and its lowest value of -$213.5 million during FY2022.
  • For the 3-year period, Fortress Biotech's EBT averaged around -$162.5 million, with its median value being -$153.6 million (2023).
  • In the last 5 years, Fortress Biotech's EBT crashed by 59.80% in 2021 and then increased by 28.03% in 2023.
  • Fortress Biotech's EBT (Yearly) stood at -$102.8 million in 2020, then plummeted by 59.80% to -$164.4 million in 2021, then decreased by 29.88% to -$213.5 million in 2022, then rose by 28.03% to -$153.6 million in 2023, then increased by 21.54% to -$120.5 million in 2024.